Oncocyte terminates Marcum as auditor, engages CBIZ CPAs for FY 2025

Insight Molecular Diagnostics Inc.

Terminated Marcum LLP effective April 11, 2025; engaged CBIZ CPAs P.C. on April 16, 2025 as auditor for FY 2025.
Change follows CBIZ CPAs' acquisition of Marcum's attest business effective November 1, 2024.
No disagreements or reportable events occurred during Marcum's tenure through April 11, 2025.
Marcum's reports for FY 2023 and 2024 were unqualified except for a going-concern note in 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.